Literature DB >> 24188586

T-cell suppression by red blood cells is dependent on intact cells and is a consequence of blood bank processing.

Kristin Long1, Cindy Meier, Andrew Bernard, Dennis Williams, Dan Davenport, Jerold Woodward.   

Abstract

BACKGROUND: Red blood cells (RBCs) suppress T-cell responsiveness through a mechanism requiring cell-cell contact. Questions remain as to whether this effect is an allogeneic response, related to cell death, or dependent on particular components of the RBCs. STUDY DESIGN AND METHODS: Peripheral T cells were isolated from healthy donors and exposed to stored allogeneic RBCs or autologous RBCs after processing. RBCs were lysed by hypotonic solvent to produce cellular ghosts. Tritiated thymidine proliferation assays were utilized. Cultures were saturated with interleukin (IL)-2 to determine whether impaired IL-2 synthesis played a role.
RESULTS: T-cell proliferation was suppressed by both autologous and allogeneic RBCs. RBC membrane integrity does enhance T-cell suppression. T-cell death is not responsible for the suppressive changes. IL-2 synthesis is suppressed in RBC-exposed T cells but addition of exogenous IL-2 does not rescue proliferative capabilities. Proliferation of T cells was inhibited with RBC exposure but mitigated with the addition of fresh RBCs.
CONCLUSIONS: T-cell suppression is enhanced by intact RBCs but this effect is unrelated solely to alloantigens. Neither apoptosis nor necrosis of T cells contributes to this phenomenon. IL-2 synthesis is suppressed after RBC exposure as a consequence of T-cell inhibition, but is not the primary cause of suppression. Fresh RBCs do not mediate T-cell suppression, indicating that changes in the RBC and development of the storage lesion may occur during initial blood bank processing.
© 2013 American Association of Blood Banks.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24188586      PMCID: PMC4344125          DOI: 10.1111/trf.12472

Source DB:  PubMed          Journal:  Transfusion        ISSN: 0041-1132            Impact factor:   3.157


  24 in total

1.  Red blood cell storage and transfusion-related immunomodulation.

Authors:  Rosemary L Sparrow
Journal:  Blood Transfus       Date:  2010-06       Impact factor: 3.443

2.  Differential effects of plasma and red blood cell transfusions on acute lung injury and infection risk following liver transplantation.

Authors:  Alexander B Benson; James R Burton; Gregory L Austin; Scott W Biggins; Michael A Zimmerman; Igal Kam; Susan Mandell; Christopher C Silliman; Hugo Rosen; Marc Moss
Journal:  Liver Transpl       Date:  2011-02       Impact factor: 5.799

3.  Red blood cell age and potentiation of transfusion-related pathology in trauma patients.

Authors:  Jordan A Weinberg; Scott R Barnum; Rakesh P Patel
Journal:  Transfusion       Date:  2011-04       Impact factor: 3.157

Review 4.  Transfusion-related immunomodulation: a second hit in an inflammatory cascade?

Authors:  Y M Bilgin; A Brand
Journal:  Vox Sang       Date:  2008-11       Impact factor: 2.144

Review 5.  Erythrocyte ageing in vivo and in vitro: structural aspects and implications for transfusion.

Authors:  G J C G M Bosman; J M Werre; F L A Willekens; V M J Novotný
Journal:  Transfus Med       Date:  2008-12       Impact factor: 2.019

Review 6.  Meta-analysis of clinical studies of the purported deleterious effects of "old" (versus "fresh") red blood cells: are we at equipoise?

Authors:  Eleftherios C Vamvakas
Journal:  Transfusion       Date:  2009-11-20       Impact factor: 3.157

7.  Addressing the question of the effect of RBC storage on clinical outcomes: the Red Cell Storage Duration Study (RECESS) (Section 7).

Authors:  M E Steiner; S F Assmann; J H Levy; J Marshall; S Pulkrabek; S R Sloan; D Triulzi; C P Stowell
Journal:  Transfus Apher Sci       Date:  2010-07-23       Impact factor: 1.764

8.  Storage time of allogeneic red blood cells is associated with risk of severe postoperative infection after coronary artery bypass grafting.

Authors:  Jan Jesper Andreasen; Claus Dethlefsen; Ivy S Modrau; John Baech; Henrik C Schonheyder; Jens K Moeller; Soren P Johnsen
Journal:  Eur J Cardiothorac Surg       Date:  2010-08-10       Impact factor: 4.191

9.  Packed red blood cells suppress T-cell proliferation through a process involving cell-cell contact.

Authors:  Andrew Bernard; Cindy Meier; Marty Ward; Tyler Browning; Ashley Montgomery; Michael Kasten; Charles Snow; Erin Manning; Jerold Woodward
Journal:  J Trauma       Date:  2010-08

10.  Length of storage and in vitro immunomodulation induced by prestorage leukoreduced red blood cells.

Authors:  Oliver Karam; Marisa Tucci; Baruch J Toledano; Nancy Robitaille; Jocelyne Cousineau; Louis Thibault; Jacques Lacroix; Françoise Le Deist
Journal:  Transfusion       Date:  2009-07-17       Impact factor: 3.157

View more
  8 in total

1.  Effect of storage period of red blood cell suspensions on helper T-cell subpopulations.

Authors:  Salih H Bal; Yasemin Heper; Levent T Kumaş; Furkan Guvenc; Ferah Budak; Güher Göral; Haluk B Oral
Journal:  Blood Transfus       Date:  2017-03-15       Impact factor: 3.443

Review 2.  Red blood cell storage lesion: causes and potential clinical consequences.

Authors:  Tatsuro Yoshida; Michel Prudent; Angelo D'alessandro
Journal:  Blood Transfus       Date:  2019-01       Impact factor: 3.443

Review 3.  Mechanisms of red blood cell transfusion-related immunomodulation.

Authors:  Kenneth E Remy; Mark W Hall; Jill Cholette; Nicole P Juffermans; Kathleen Nicol; Allan Doctor; Neil Blumberg; Philip C Spinella; Philip J Norris; Mary K Dahmer; Jennifer A Muszynski
Journal:  Transfusion       Date:  2018-01-30       Impact factor: 3.157

Review 4.  Scalable Manufacturing of CAR T cells for Cancer Immunotherapy.

Authors:  Mohamed Abou-El-Enein; Magdi Elsallab; Gerhard Bauer; Barbara Savoldo; Steven A Feldman; Andrew D Fesnak; Helen E Heslop; Peter Marks; Brian G Till
Journal:  Blood Cancer Discov       Date:  2021-08-03

5.  Red blood cells exposed to cancer cells in culture have altered cytokine profiles and immune function.

Authors:  Elisabeth Karsten; Edmond Breen; Sharon A McCracken; Stephen Clarke; Benjamin R Herbert
Journal:  Sci Rep       Date:  2020-05-07       Impact factor: 4.379

6.  Red blood cell transfusions impact response rates to immunotherapy in patients with solid malignant tumors.

Authors:  Rebekka Mispelbaum; Sandra Tessa Hattenhauer; Peter Brossart; Annkristin Heine
Journal:  Front Immunol       Date:  2022-09-08       Impact factor: 8.786

7.  Development and Validation of a Machine Learning-Based Nomogram for Prediction of Ankylosing Spondylitis.

Authors:  Jichong Zhu; Qing Lu; Tuo Liang; Hao Li; Chenxin Zhou; Shaofeng Wu; Tianyou Chen; Jiarui Chen; Guobing Deng; Yuanlin Yao; Shian Liao; Chaojie Yu; Shengsheng Huang; Xuhua Sun; Liyi Chen; Wenkang Chen; Zhen Ye; Hao Guo; Wuhua Chen; Wenyong Jiang; Binguang Fan; Xiang Tao; Xinli Zhan; Chong Liu
Journal:  Rheumatol Ther       Date:  2022-08-06

Review 8.  Transfusion-related immunomodulation: review of the literature and implications for pediatric critical illness.

Authors:  Jennifer A Muszynski; Philip C Spinella; Jill M Cholette; Jason P Acker; Mark W Hall; Nicole P Juffermans; Daniel P Kelly; Neil Blumberg; Kathleen Nicol; Jennifer Liedel; Allan Doctor; Kenneth E Remy; Marisa Tucci; Jacques Lacroix; Philip J Norris
Journal:  Transfusion       Date:  2016-10-02       Impact factor: 3.157

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.